Action ZYME ZYMEWORKS INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Zymeworks Inc.

Actions

ZYME

US98985Y1082

Marché Fermé - Nasdaq
Autres places de cotation
 22:30:01 03/05/2024 		Varia. 5j. Varia. 1 janv.
9,2 USD +2,22% Graphique intraday de Zymeworks Inc. +11,38% -11,45%
02/05 Transcript : Zymeworks Inc., Q1 2024 Earnings Call, May 02, 2024
02/05 Zymeworks Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results
Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results
Zymeworks Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Unlocking the potential of antibody drug conjugates
Zymeworks Announces Participation in Upcoming Investor Conferences
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME
Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
Zymeworks Inc. Presents New Data from Multiple Preclinical Development Programs At 2024 American Association for Cancer Research Annual Meeting
Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME
Zymeworks Inc. Removes Christopher Astle from the Positions of Chief Financial Officer
Zymeworks Inc. Removes Dr. Christopher Astle from the Positions of Senior Vice President
Zymeworks Inc. Announces the Composition of the Committees
Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors
Zymeworks Inc. Announces Appointment of Neil Gallagher to Its Board of Directors and as Member of the Research and Development Committee, Effective April 2, 2024
Zymeworks Announces Participation in Upcoming Investor Conferences
Zymeworks Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action ZYME
  4. Actualités Zymeworks Inc.
  5. Autres langues